Answer
Women must not breastfeed during treatment with Ogsiveo or for 1 week after the last dose because of the potential for serious adverse reactions in a breastfed child.
Sources for this answer
- Ogsiveo 150 mg film coated tabletsMerck · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked